Search form

Topics:

ubmslateCL-logo-ubm

CL Mobile Menu

Alyce Oliver, PhD, MD

Alyce Oliver, PhD, MD

Posts by Author

Along with the release of revised guidelines, several pharmacological therapies have become available or are under investigation to help improve outcomes in patients with osteoporosis.

Following the release of revised National Osteoporosis Foundation guidelines and of the World Health Organization’s fracture risk assessment tool, several pharmacological therapies have become available to help improve outcomes in patients with osteoporosis.

Osteoporosis is a major public health threat that affects more than half of persons older than 50 years. The most common bone disease in humans, osteoporosis is associated with pain, disability, and increased risk of mortality.

By clicking Accept, you agree to become a member of the UBM Medica Community.